Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells

Yicun Wang(Hebei GEO University), Le Qu(Nanjing General Hospital of Nanjing Military Command), Kun‐Liang Guan(Westlake University), Haowei He(Nanjing General Hospital of Nanjing Military Command), Ke Zhong(Nanjing General Hospital of Nanjing Military Command), Xiaoming Yi(Nanjing General Hospital of Nanjing Military Command), Changjie Shi(Second Affiliated Hospital of Nanjing Medical University), Guangxin Zhou(China Pharmaceutical University), Hui Chen(Nanjing General Hospital of Nanjing Military Command), Xiaoxia Wang(Wenzhou Medical University), Yang Yang(Jinling Institute of Technology), Cheng Chen(Nanchang University), Linhui Wang(Second Military Medical University), Xiaoyuan Chu(Nanjing University of Chinese Medicine), Xiaodie Zhou(Second Military Medical University), Xuhui Zhou(Shanghai Jiao Tong University), Jingping Ge(Nanjing General Hospital of Nanjing Military Command), Zhenjie Wu(Second Military Medical University), Jinhui Wu(Second Military Medical University), Wenquan Zhou(Nanjing General Hospital of Nanjing Military Command), Yaoming Li(Beijing Forestry University), Gwen Lomberk(Second Military Medical University), Xiaodie Zhou(Second Military Medical University), Jianning Zhao(Second Affiliated Hospital of Nanjing Medical University), Chengwu Xiao(Second Military Medical University), Bing Liu(Second Military Medical University), Qiu Rao(Indiana University School of Medicine)
Science Advances
January 27, 2021
Cited by 41


Related Papers